<DOC>
	<DOCNO>NCT00332917</DOCNO>
	<brief_summary>This multicenter , 6 month open label safety extension study patient willing eligible continue pivotal , double-blind S308.3.001 trial</brief_summary>
	<brief_title>An Open Label SLV308 Safety Extension Study S308.3.001 Early PD Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients complete S308.3.001 trial Patients medically relevant abnormal finding ( ECG , physical examination , AEs ) end maintenance phase ( visit M6 , week 24 ) study S308.3.001</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Parkinson 's disease</keyword>
</DOC>